International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis

DL Bhatt, PG Steg, EM Ohman, AT Hirsch, Y Ikeda… - Jama, 2006 - jamanetwork.com
ContextAtherothrombosis is the leading cause of cardiovascular morbidity and mortality
around the globe. To date, no single international database has characterized the …

International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis

DL Bhatt, PG Steg, EM Ohman, AT Hirsch… - Journal of the …, 2006 - experts.umn.edu
Context: Atherothrombosis is the leading cause of cardiovascular morbidity and mortality
around the globe. To date, no single international database has characterized the …

[引用][C] International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis

L Ataíde Junior, J Atie, Á Avezum, F Bandeira… - JAMA, 2006 - repositorio.usp.br
ReP USP - Detalhe do registro: International prevalence, recognition, and treatment of
cardiovascular risk factors in outpatients with atherothrombosis Home About USP Schools …

[引用][C] International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis

DL BHATT, PG STEG, PWF WILSON… - JAMA, the journal of …, 2006 - pascal-francis.inist.fr
International prevalence, recognition, and treatment of cardiovascular risk factors in
outpatients with atherothrombosis CNRS Inist Pascal-Francis CNRS Pascal and Francis …

International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis.

DL Bhatt, PG Steg, EM Ohman, AT Hirsch, Y Ikeda… - JAMA, 2006 - europepmc.org
International prevalence, recognition, and treatment of cardiovascular risk factors in
outpatients with atherothrombosis. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

[PDF][PDF] International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis

DL Bhatt, PG Steg, EM Ohman, AT Hirsch… - …, 2006 - … .farmacoterapia-sanidadmadrid.org
Objective To determine whether atherosclerosis risk factor prevalence and treatment would
demonstrate comparable patterns in many countries around the world. Design, Setting, and …

International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis.

DL Bhatt, PG Steg, EM Ohman, AT Hirsch, Y Ikeda… - 2006 - cabidigitallibrary.org
Context: Atherothrombosis is the leading cause of cardiovascular morbidity and mortality
around the globe. To date, no single international database has characterized the …

International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis

DL Bhatt, PG Steg, EM Ohman, AT Hirsch, Y Ikeda… - 2006 - dro.deakin.edu.au
CONTEXT: Atherothrombosis is the leading cause of cardiovascular morbidity and mortality
around the globe. To date, no single international database has characterized the …

International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis.

DL Bhatt, PG Steg, EM Ohman… - JAMA: Journal of …, 2006 - search.ebscohost.com
Context Atherothrombosis is the leading cause of cardiovascular morbidity and mortality
around the globe. To date, no single international database has characterized the …

[PDF][PDF] International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis

DL Bhatt, PG Steg, EM Ohman, AT Hirsch, Y Ikeda… - JAMA, 2006 - academia.edu
Objective To determine whether atherosclerosis risk factor prevalence and treatment would
demonstrate comparable patterns in many countries around the world. Design, Setting, and …